AROC vs PFE · P/E 21, rev $1.16B vs P/E 20, rev $62.58B
Archrock Inc (AROC) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Archrock Inc (AROC) is a oil & gas equipment & services company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported AROC revenue for 2024-12-31 was $1.16B. Net income was $172.2M. Revenue was up 16.9% from 2023-12-31 to 2024-12-31. AROC currently screens at market cap $4.37B and trailing P/E 20.8.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
AROC currently screens at market cap $4.37B and trailing P/E 20.8. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the AROC and PFE stock pages for the full models.
Not investment advice.